BIOLASE MG LLC – Trademark Portfolio
Entity Type: 16
BIOLASE MG LLC holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 11 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes. Currently, 18 trademarks are registered. Notable registered marks include EPIC, WCLI, IPLUS, EZLASE, and I-LASE. The owner is based in FOOTHILL RANCH, CA.
27042 TOWNE CENTRE DRIVE
SUITE 270
FOOTHILL RANCH, CA 92610
Showing of trademarks Trademarks
Trademark Classifications
BIOLASE MG LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does BIOLASE MG LLC have?
BIOLASE MG LLC has 19 U.S. trademarks filed with the USPTO. Of these, 18 registered, 1 cancelled.
What trademark classes does BIOLASE MG LLC file in?
BIOLASE MG LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are BIOLASE MG LLC's most well-known trademarks?
BIOLASE MG LLC's registered trademark portfolio includes well-known marks such as EPIC, WCLI, IPLUS, EZLASE, and I-LASE. These are among 18 currently registered trademarks in the portfolio.
What is BIOLASE MG LLC's trademark registration success rate?
BIOLASE MG LLC has a 95% trademark registration rate, with 18 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.